Story perspectives

Newborns in England to Screen for Life-Saving HT1

10/14/2025

25 4

Summary

Story summary

Newborns in England will be screened for hereditary tyrosinaemia type 1 (HT1) under the NHS Newborn Blood Spot Screening Programme, with tests at five days after birth.
HT1 affects about one in seven babies annually in the UK, causing toxic buildup in the blood if untreated.
Early detection enables immediate treatment with medication and dietary adjustments, improving health outcomes.
The screening reassures families and prevents severe complications, thereby saving lives.

1 of 1

Story summary

Newborns in England will be screened for hereditary tyrosinaemia type 1 (HT1) under the NHS Newborn Blood Spot Screening Programme, with tests at five days after birth.
HT1 affects about one in seven babies annually in the UK, causing toxic buildup in the blood if untreated.
Early detection enables immediate treatment with medication and dietary adjustments, improving health outcomes.
The screening reassures families and prevents severe complications, thereby saving lives.